Abiopharma

🔍 Brennan Kieran (Executive)

Company: TSS, Inc. (TSSI)

Report Date: 2026-03-23-05:00

Detailed Transactions and Holdings:

• Acquired 2,500 shares of Common Stock (Direct)
  Date: 2026-03-23-05:00 | Code: A | equity_swap_involved: false | shares_owned_after: 281,637.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 304 shares of Common Stock at $12.4 per share (Direct)
  Date: 2026-03-23-05:00 | Code: F | equity_swap_involved: false | shares_owned_after: 281,333.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: These shares of common stock represent restricted stock granted to Mr. Brennan that are subject to financial performance vesting criteria that has been achieved. The restricted stock vests in installments as follows assuming Mr. Brennan remains employed through the applicable vesting dates: (1) 1,250 shares vested on March 23, 2026, and (2) 1,250 shares will vest on January 1, 2027, and are subject to forfeiture.
• F2: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock awards.